andomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
Brims F., Gunatilake S., Lawrie I., Marshall L., Fogg C., Qi C., Maskell N., Forbes K., Rahman N., Morris S., Gerry S., Chauhan A.